Trehalose prevents adipocyte hypertrophy and mitigates insulin resistance

Nutrition Research

Volumn 30, Issue 12, 2010, Pages 840-848

  Arai, Chikako ^a   Arai, Norie ^a   Mizote, Akiko ^a   Kohno, Keizo ^a   Iwaki, Kanso ^a   Hanaya, Toshiharu ^a   Arai, Shigeyuki ^a   Ushio, Simpei ^a   Fukuda, Shigeharu ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

Adipocyte; Hypertrophy; Insulin resistance; Mice; Trehalose

Indexed keywords

ADIPONECTIN; CARBOHYDRATE; DRINKING WATER; FRUCTOSE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; MALTOSE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; TREHALOSE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CARBOHYDRATE INTAKE; CELL SIZE; CONTROLLED STUDY; CYTOMEGALY; DIET THERAPY; DISEASE COURSE; DOWN REGULATION; FEMALE; FOOD COMPOSITION; FUNCTIONAL FOOD; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GROWTH INHIBITION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; LIPID STORAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRITIONAL ASSESSMENT; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; THERAPY EFFECT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOCYTES; ANIMALS; CHEMOKINE CCL2; DIETARY FATS; DIETARY SUCROSE; FEMALE; GENE EXPRESSION; HYPERTROPHY; INSULIN; INSULIN RESISTANCE; MICE; MICE, INBRED C57BL; OBESITY; RNA, MESSENGER; TREHALOSE;

MUS; ZEA MAYS;

EID: 78649920413     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2010.10.009     Document Type: Article

References (37)

1. Periwal V., Chow C.C., Bergman R.N., Ricks M., Vega G.L., Sumner A.E. Evaluation of quantitative models of the effect of insulin on lipolysis and glucose disposal. Am J Physiol Regul Integr Comp Physiol 2008, 295:R1089-R1096.
2. Blüher S., Kratzsch J., Kiess W. Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. Best Pract Res Clin Endocrinol Metab 2005, 19:577-587.
3. Colaco C., Sen S., Thangavelu M., Pinder S., Rose B. Extraordinary stability of enzymes dried in trehalose: simplified molecular biology. Bio/Technology 1992, 10:1007-1010.
4. Sugimoto T. Production of trehalose by starch-glycation method with enzymes and its use. Food Ind 1995, 38:34-39. (in Japanese).
5. Nishizaki Y., Yoshizane C., Toshimori Y., Arai N., Akamatsu S., Hanaya T., et al. Disaccharide-trehalose inhibits bone resorption in ovariectomized mice. Nutr Res 2000, 20:653-664.
6. Arai C., Kohguchi M., Akamatsu S., Arai N., Yoshizane C., Hasegawa N., et al. Trehalose suppresses lipopolysaccharide-induced osteoclastogenesis bone marrow in mice. Nutr Res 2001, 21:993-999.
7. Tanaka M., Machida Y., Niu S., Ikeda T., Jana N.R., Doi H., et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med 2004, 10:148-154.
8. Oku T., Nakamura S. Estimation of intestinal trehalase activity from a laxative threshold of trehalose and lactulose on healthy female subjects. Eur J Clin Nutr 2000, 54:783-788.
9. Nishino N., Tamori Y., Kasuga M. Insulin efficiently stores triglycerides in adipocytes by inhibiting lipolysis and repressing PGC-1α induction. Kobe J Med Sci 2007, 53:99-106.
10. Olefsky J.M. The effects of spontaneous obesity on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest 1976, 57:842-851.
11. Koya-Miyata S., Arai N., Mizote A., Taniguchi Y., Ushio S., Iwaki K., et al. Propolis prevents diet-induced hyperlipidemia and mitigates weight gain in diet-induced obesity in mice. Biol Pharm Bull 2009, 32:2022-2028.
12. Ostman J., Arner P., Engfeldt P., Kager L. Regional differences in the control of lipolysis in human adipose tissue. Metabolism 1979, 28:1198-11205.
13. Keno Y., Matsuzawa Y., Tokunaga K., Fujioka S., Kawamoto T., Kobatake T., et al. High sucrose diet increases visceral fat accumulation in VMH-lesioned obese rats. Int J Obes 1991, 15:205-211.
14. Ferranti S., Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008, 54:945-955.
15. Gudmand-Høyer E., Skovbjerg H. Disaccharide digestion and maldigestion. Scand J Gastroenterol Suppl 1996, 216:111-121.
16. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010, 316:129-139.
17. Okuno A., Tamemoto H., Tobe K., Ueki K., Mori Y., Iwamoto K., et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998, 101:1354-1361.
18. Maffeis C., Silvagni D., Bonadonna R., Grezzani A., Banzato C., Tatò L. Fat cell size, insulin sensitivity, and inflammation in obese children. J Pediatr 2007, 151:647-652.
19. Yamauchi T., Kamon J., Waki H., Murakami K., Motojima K., Komeda K., et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. J Biol Chem 2001, 276:41245-41254.
20. O'Connell J., Lynch L., Cawood T.J., Kwasnik A., Nolan N., Geoghegan J., et al. The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLos One 2010, 5:e9997.
21. Muñoz M.C., Giani J.F., Dominici F.P., Turyn D., Toblli J.E. Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats. J Hypertens 2009, 27:2409-2420.
22. Roberts R., Hodson L., Dennis A.L., Neville M.J., Humphreys S.M., Harnden K.E., et al. Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 2009, 52:882-890.
23. Nascimento F.A., Barbosa-da-Silva S., Fernandes-Santos C., Mandarim-de-Lacerda C.A., Aguila M.B. Adipose tissue, liver and pancreas structural alterations in C57BL/6 mice fed high-fat-high-sucrose diet supplemented with fish oil (n-3 fatty acid rich oil). Exp Toxicol Pathol 2010, 62:17-25.
24. Huang H.L., Hong Y.W., Wong Y.H., Chen Y.N., Chyuan J.H., Huang C.J., et al. Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats. Br J Nutr 2008, 99:230-239.
25. Lorenzo M., Fernández-Veledo S., Vila-Bedmar R., Garcia-Guerra L., Alvaro C.D., Nieto-Vazquez I. Insulin resistance induced by tumor necrosis factor-γ in myocytes and brown adipocytes. J Anim Sci 2008, 86:94E-104E.
26. Chen B., Wei J., Wang W., Cui G., Zhao Y., Zhu X., et al. Identification of signaling pathways involved in aberrant production of adipokines in adipocytes undergoing oxidative stress. Arch Med Res 2009, 40:241-248.
27. Nakashima R., Kamei N., Yamane K., Nakanishi S., Nakashima A., Kohno N. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 2006, 91:3873-3877.
28. Seino Y., Hirose H., Saito I., Itoh H. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men. Metabolism 2009, 58:355-360.
29. Maki K.C., Kanter M., Rains T.M., Hess S.P., Geohas J. Acute effects of low insulinemic sweeteners on postprandial insulin and glucose concentrations in obese men. Int J Food Sci Nutr 2009, 60:48-55.
30. Sartipy P., Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. PNAS 2003, 100:7265-7270.
31. Tateya S., Tamori Y., Kawaguchi T., Kanda H., Kasuga M. An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice. Endocrinology 2010, 151:971-979.
32. Ito A., Suganami T., Miyamoto Y., Yoshimasa Y., Takeya M., Kamei Y., et al. Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy. J Biol Chem 2007, 282:25445-25452.
33. Yamanashi Y., Baltimore D. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell 1997, 88:205-211.
34. Hosooka T., Noguchi T., Kotani K., Nakamura T., Sakaue H., Inoue H., et al. Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-γ phosphorylation. Nat Med 2008, 14:188-193.
35. Lijnen H.R. Elements of the fibrinolytic system. Ann N Y Acad Sci 2001, 936:226-236.
36. Bastard J.P., Piéroni L. Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity. Biomed Pharmacother 1999, 53:455-461.
37. Ma L.J., Mao S.L., Taylor K.L., Kanjanabuch T., Guan Y., Zhang Y., et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 2004, 53:336-346.